Attachment B – Test Tracking Form

NURSING OCCURRENCE REPORT FORM

CAMPUS: ___________________________________________________________

1. Describe the events, including dates, full names of all personnel and students involved. (Please use other side if necessary.)

2. What actions were taken relevant to this occurrence? Include name, dates and times of supervisory personnel and physicians, if any, notified.

3. Describe your recommendations for avoiding a similar occurrence in the future (if relevant).

4. Are there any documents or materials submitted with this report? _______ Yes _______ No
Describe.

Print Name of Reporter:_______________________________________________________
Signature of Reporter: ___________________________________ Date: _____________
Head Nurse: _____________________________________ ______ Date: _____________
Director of Nursing: ______________________________________ Date: _____________
Rev. 3/04

It is the policy of Hillcrest Educational Centers, Inc. (HEC) that all medical care providers will implement the procedures described in this policy relative to waived testing.

Purpose: To provide a framework for waived tests by establishing minimum requirements for quality control, responsibility of the testing personnel and required reporting for waived tests including Clinical Laboratory Improvement Amendments of 1988 (CLIA 88), Department of Public Health and JCAHO standards.

Applicability: All personnel in the residential sites nursing departments performing waived testing. The current Nursing Director under the direction of the Medical Director will serve as the laboratory director and oversee all pertinent policies and procedures.

Definitions:

CLIA: Clinical Laboratory Amendments of 1988. When an individual performs a test or interprets the results of a test, it is an activity regulated by CLIA.

Waived testing: A wide variety of simple laboratory examinations and procedures that are cleared by the FDA for home use. These tests employ methodologies that are simple and accurate and pose no reasonable risk of harm to the patient. These tests may include but are not limited to urine multistix, urine drug screen, rapid strep test, urine pregnancy test, blood glucose test.

Certification:

CLIA application for certificate of waiver will be obtained from the Massachusetts Department of Health and Human Services and maintained every 2 years.

Standards:

Personnel performing and supervising the waived testing will be identified and adequately trained by the Laboratory Director

Satisfactory staff competencies will be established and performed annually

Written records of competence will be maintained on each campus. (See attached record)

Specific testing processes from the manufacturer will be current and readily available in the “Waived Testing Manual.”

Quality-control checks will be conducted on each kit as recommended by the manufacturer. One person at each campus will be assigned to complete the checks and maintain a written record in the “Waived Testing Manual.” (See attached)

Test records will be kept in the “Waived Testing Manual” as well as the client record. (See attached flow sheet).

All urine tests will be sent to the contract laboratory for confirmatory testing.

Quality Control Testing Flowsheet

Record of CLIA Medical Testing

CLIA waived kits available through Moore Medical

82790- Moore brand HCG cassette- Alere North America, Inc/Form (manufacturer) 877-441-7440

82808 -6 Panel drug test icassette- Instant technologies (manufacturer) 800-340-4029

82792- Moore brand Strep A dipstick- Alere North America Inc/Form (manufacturer) 877-441-7440

32403- Multistix 10SG- Siemans Healthcare Diag/Bayer (manufacturer)
800-255-3232

Controls

82794 HCG Controls
92518 Drug Screen Controls- ICassette
55607 Multistix Controls

SAMPLE GLUCOSE TESTING BY FINGER STICK PROCEDURE
I. Purpose
To determine blood sugar level. Testing blood sugar is an integral part of
diabetes management. Testing helps monitor diabetes and make adjustments in
diet and exercise regimen as needed. The goal is to keep blood sugar level as
close to normal as possible. In doing so, long term health problems caused by
abnormal blood sugar levels may be delayed or prevented.
II. Specimen
One large drop of whole blood collected by finger stick at the time of testing.
Glucose tests are to be performed as indicated by physician or nurse.
III. Materials
One Touch Basic Meter
Test Strips
Lancets
Penlet II
Alcohol Prep Pads
Gloves
Sharps Container
IV. Procedure
1. Wash hands and put on gloves.
2. Ask consumer to wash hands with soap and warm water and dry thoroughly
to clean area for prick.
3. Press the On/ Off Button on Meter.
4. Press C Button until the code number matches the code number on the Test
Strip package. The Meter will remember this code until it is changed for a
new package of Test Strips.
5. Insert test strip
6. Remove Penlet II Cap and insert Lancet by pushing it into the Lancet holder.
Twist off the protective disk and replace Penlet II Cap.
7. Cock the Penlet II by pulling out the dark gray sliding barrel on the end of the
device.
8. Place Penlet II against the side of finger and press the dark gray Release
Button on its side. Be sure to rotate which finger you use to avoid soreness
or callouses.
9. Squeeze the finger gently to get a large, hanging drop of blood.
10. Apply drop of blood to test spot by only touching the drop to the test spot.
Allow 45 seconds for results.
11. Use caution when removing the Lancet and Penlet II Cap. Remove cap and
grasp the dark gray T-Shaped prongs. Point the Lancet down and away from
you into the sharps container. Pull back on the dark gray sliding barrel until
the Lancet drops out into the sharps container.
12. Remove Test Strip and discard after obtaining and documenting results.
13. Remove gloves and wash hands.
V. Interpretation
1. Follow physician/ nurse orders regarding interpretation of test results.
Client’s home staff must communicate to habilitation staff any changes in
physician/ nurse orders regarding glucose levels as changes occur. Current
physician orders must be on site. Test results and any interventions must be
documented and communicated to home staff when client returns home.
VI. Quality Control
1. Check the One Touch II meter using Normal Glucose Control Solution-Blue
Formula, which is available from drug stores or Authorized Life-Scan
Distributor. To do a Control solution test, follow the same procedure you
would if you were testing a blood sample. The Control Solution results will
appear on the meter display. The acceptable level for the One Touch Normal
Control Solution- Blue Formula is marked on the test strip vial or the foil
wrapper. In addition, a Check Strip is included with the meter. Follow
manufacturer’s instruction for use of the Check Strip.
2. Use the Glucose Control Solution at least once a week, when using a new
package of Test Strips, or whenever the meter is suspected to not be working
properly. Use Check Strip at least once a week, after cleaning the meter,
whenever results seem to be inaccurate or inconsistent, or whenever the
meter’s “NOT OK REDO” message appears on the meter.
3. Document quality control results in maintenance log.

*******************************************************************

SAMPLE KETONE TESTING BY URINE DIP PROCEDURE
I. Purpose
To determine whether ketones are being spilled into urine. An individual with
diabetes is likely to spill ketones into urine as a result of burning too much fat.
Burning too much fat and producing too many ketones may be a sign that an
individual’s diabetes is out of control. When this occurs, a complication called
ketoacidosis develops which may lead to serious medical complications such as
coma.
II. Specimen
Fresh urine sample voided within 10 minutes. If there is a greater than 10 min
delay in testing specimen, obtain a second specimen.
III. Materials
Clean and dry paper cup
Ketostix Reagent Strip
Gloves
IV. Procedure
1. Put on gloves and hand client clean and dry paper cup. Have client collect
urine sample in bathroom. Have client leave specimen in bathroom.
2. Remove strip from bottle replace cap immediately and tightly. Do not touch
test area of strip. Check expiration date printed on the bottle label. If date
has passed, discard and retest with strips from a new bottle. If the bottle has
been opened, check the date recorded from when it was first opened.
3. Dip the end of the strip into fresh urine sample and remove it immediately
drawing the edge of strip against rim of the urine container to remove excess
urine.
4. Begin timing and at exactly 15 seconds, match the reagent area to the ketone
color chart. Ignore color changes that occur after 15 seconds.
5. Document results and discard test strip.
V. Interpretation
1. Follow physician/ nurse orders regarding interpretation of test results.
Client’s home staff must communicate to habilitation staff any changes in
physician/ nurse orders regarding changes occur. Current physician orders
must be on site. Test results and any interventions must be documented and
communicated to home staff when client returns home.
VI. Quality Control
1. Always check the expiration date on the bottle. A new bottle can be used for
6 month after being opened. Always write the date you open a bottle on the
label. Do not use product (opened or unopened) after expiration date.

*********************************************************************

FASTECT II DRUG SCREEN DIPSTICK TEST
I. Purpose
The Fastect II Drug Screen Dipstick Test is an in vitro screen test for the rapid
detection of multiple drugs and drug metabolites in human urine at or above the
determined cutoff concentrations. This test provides only a preliminary screening
test result.
II. Specimen
Only freshly voided, untreated urine obtained in a clean collection cup should be
used. Urine samples should be collected so that testing may be performed as
soon as possible, preferably during the same day.
III. Materials
Dipstick Test Device
Clean collection cup
Disposable towel upon which test device laid
Gloves
IV. Procedure (per Manufacturer’s manual)
1. Test device and donor sample (urine specimen) should be at room
temperature. Do not open sealed pouch until ready to perform the assay.
2. Remove the test device from the sealed pouch.
3. Push the sleeve on the test device all the way up.
4. Dip the sample pad of the test device into the urine sample for at least 10
seconds. Dip up to, but not beyond, the tips of the arrows.
5. Slide the sleeve down to the read indicator mark and lay the device on a level
surface.
6. Once the control band (C) appears (in 5 minutes or less) results are ready to
interpret. (Results are stable and may be interpreted up to 1 hour after the
control band forms.)
7. Record results and properly dispose of urine sample and test device.
8. Precaution: The urine sample and all materials coming in contact with the
urine sample should be handled and disposed of as if potentially infectious.
Established universal precautions must be followed.
V. Interpretation
For interpretations of results, manufacturer’s procedures must be followed:
1. Negative Results: The presence of a colored band at the control region (C)
and a colored band at a specific test region (T) regardless of the intensity
indicate that the result is negative for that particular test.
2. Positive Results: The presence of a colored band at the control region (C)
and the absence of a colored band at the test region (T) indicate a positive
result for that particular test.
3. Invalid Results: No band appears at the control region (C). The test is
inconclusive even if there is a band at the test region (T). If the test device
does not produce a band at the control region, check testing procedure,
sample, and/or control materials, and repeat the test using a new device.
VI. Quality Control (per Manufacturer’s manual)
1. The Fastech II test device has built-in internal procedural controls (See
Invalid Results above).
2. The assay is designed for use with human urine only.
3. Positive results only indicate the presence of drug/metabolites and do not
indicate or measure intoxication.
4. There is a possibility that technical or procedural errors as well as other
substances in certain foods and medication may interfere with test and cause
false results.
5. If a drug/metabolite is found present in the urine specimen, the assay does
not indicate frequency of drug use or distinguish between drugs of abuse and
certain food and/or medication.
6. If it is suspected that the sample may have been tampered with, the test
should be repeated, and a new specimen should be collected.

A. Nursing Staff
All nursing staff must fulfill Massachusetts Board of Nursing requirements to maintain licensure.

B. Other Staff
Supervisors and assistant supervisors receive CPR and First Aid training as part of their mandatory 24 hours of training per year. All staff receive training in emergency procedures, basic First Aid, medications, blood-borne pathogens and Universal Precautions.
Non-licensed staff dispensing medication to students receive training by a Registered Nurse employed by HEC, and are medication certified, consistent with Policy and Procedure.

See Infection Control Manual
See Hazardous Waste and Materials Management (EOC) Plan

All toxic substances and sharp objects are kept out of reach of the students and in secured areas. All toxic substances are labeled with contents and antidote.
All personal staff medications must be stored in a locked area. Any exception to this must be approved by the campus Nursing Dept.

See Hazardous Waste and Materials Management (EOC) Plan

A. First Aid & CPR
All staff at Hillcrest campuses are CPR and First Aid trained.
First Aid kits are stored in secure places, out of the reach of students. First Aid kits can be found in agency vehicles, in each building on the campus. In cases where there are two dormitory floors or activity areas, each floor or area would have access to at least one kit.

B. Notification & Transportation
Emergency Procedure Manuals and Emergency Phone Numbers are kept by all telephones. Each campus has a phone list specific to their geographic area.
Staff injuries incurred during the course of maintaining campus safety are assessed and treated by a nurse or supervisor. An Accident Reporting & Treatment (ART) form is completed. Any injuries requiring further care are referred to the Administrative Injury Coordinator. If an employee injury prohibits him/her from safely transporting themselves for further care, arrangement for transportation will be made by their supervisor.

Purpose: It is the policy of Hillcrest Educational Centers (HEC) to provide a safe and healthy work environment which includes proper management of exposure to potentially contaminated blood and/or body fluids. These procedures are meant to ensure that appropriate measures are taken to protect those at risk of exposure.

Background: OSHA estimates approximately 5.6 million workers in health care and other facilities are at risk of exposure to bloodborne pathogens such as the human immunodeficiency (HIV), hepatitis B (HBV) virus, hepatitis C (HCV) and other potentially infectious diseases. Those at risk include anyone whose job may require providing first-response medical care in which there is a reasonable expectation of contact with blood or other potentially infectious materials. Common exposure in settings like HEC may occur from human bites. Although they are rarely associated with the transmission of HIV or HBV infection they are associated with a significant risk for serious bacterial infection and require proper medical treatment. Prevention of exposures is critically important. Regular hand washing, appropriate use of gloves and training are steps that contribute to the prevention of complications from these exposures.
Vaccinations and Incident Reporting
HEC has a vaccination program through Occupational Health Services. This program is offered at no cost to all employees upon being hired and again to those who have an occupational exposure to bloodborne pathogens. In the event of employee exposure to bloodborne pathogens, post-exposure evaluation and follow-up will be provided at Occupational Health Services. Following any exposure incident, the affected employee should immediately report to the campus nurse on duty during normal business hours. After hours, employees are instructed to report to the Berkshire Medical Center Emergency Room. An ART form AND Post Exposure Work Sheet should be completed by the nurse, faxed to Employee Health Representative at HR, a copy should be given to the Program Manager and the original sent with the employee for further documentation by the treating physician.

Procedures after bite exposure (Student to Student or Student to Staff)
• Immediately wash the site for 5 minutes with soap and water or flush eyes with normal
saline or tap water for 15 minutes (remove and discard contact lenses) Mild bleeding should be allowed to continue
• If there is blood in the biter’s mouth it should be rinsed and spit with tap water several times
• Report the injury to a supervisor
• Contact or go to campus Nursing Department who will make an assessment and refer to pediatrician, Occupational Health Services or Emergency Department as necessary
• Initial assessment includes skin integrity (is the skin broken), documentation of the incident and those involved, and initial wound care
• If after hours, go to the Emergency Room for evaluation of a bite that has broken the skin
• Complete incident report form, ART Form and Post Exposure Worksheet. Enter a progress note in the appropriate system.
• Obtain a medical history on the source patient (biter) and have blood specimens drawn within the first 8-10 hours after exposure (consent must be obtained): Rapid HIV and Hepatitis panel. Bites occurring after Nursing hours will have arrangements made to be drawn the next morning. (Previously drawn labs are acceptable if dated in the past 60 days)
• Employees referred to Occupational Health or ER will receive an assessment and treatment which may include but is not limited to tetanus update, antibiotics, and several blood tests as recommended by treating Physician. Treatment options will be discussed on an individual basis.
• Report the results of blood testing of the source (biter) to Occupational Health as soon as available (within 24 hours if rapid HIV done). The status of the Employee should be reported to the campus at this time. If there are positive reports at any time, The Medical Directors of both HEC and Occupational Health will be notified immediately. Referral for appropriate counseling and treatment will be made.
• If exposure occurs when there is no nurse available, a call should be placed to the campus on call Nurse to decide the course of action.
Procedures after body fluid exposure (Student to Student or Student to Staff)
In the event of an accidental exposure to blood or body fluids (e.g., needlestick, blood or body fluid contamination to a cut or scrape, mucous membrane exposure)
• Immediately wash the area for 10 minutes with soap and water or flush eyes with normal
saline or tap water for 15 minutes (remove and discard contact lenses)or rinse mouth for several minutes
• Report the injury to a supervisor
• Contact or go to campus Nursing Department who will make an assessment and refer to pediatrician or Occupational Health Services as necessary
• Initial assessment includes skin integrity (is the skin broken), documentation of those involved, and initial wound care
• If after hours, go to the Emergency Room for evaluation
• Complete incident report form, ART Form and Post Exposure Worksheet. Enter nursing note in appropriate system.
• Obtain a medical history on the source patient and have blood specimens drawn within the first 8-10 hours after exposure (consent must be obtained): Rapid HIV and Hepatitis panel. Bites occurring after Nursing hours will have arrangements made to be
drawn the next morning.(Previously drawn labs are acceptable if dated in the past 60 days)
• Employees referred to Occupational Health or ER will receive an assessment and treatment which may include but is not limited to tetanus update, antibiotics, and several blood tests as recommended by treating Physician. Treatment options will be discussed on an individual basis.
• Report the results of blood testing of the source (biter) to Occupational Health as soon as available (within 24 hours if rapid HIV done). The status of the Employee should be reported to the campus at this time. If there are positive reports at any time, The Medical Directors of both HEC and Occupational Health will be notified immediately. Referral for appropriate counseling and treatment will be made.
• If exposure occurs when there is no nurse available, a call should be placed to the campus on call Nurse to decide the course of action.

Post Exposure Worksheet

EMPLOYEE HEALTH CARE
Employees

HEC will not dismiss, refuse to hire, refuse to advance in employment, or otherwise discriminate against persons with HIV infection, believed to have HIV infection, or persons believed to be at risk of HIV infection.
HEC will not require that employee or prospective employees disclose their HIV status.
HEC will not require that employees or prospective employees undergo HIV testing as a condition of application or employment.
Information voluntarily provided by an HEC employee of their HIV status shall be kept confidential and contained in a separate medical file.
If requested to do so, HEC will make every effort to accommodate an employee diagnosed with HIV, AIDS, or any other infectious disease.

A. Pre-Employment Requirements
All Hillcrest Educational Centers employees must have a physical examination and essential functions testing prior to starting employment. This examination, which includes tuberculosis screening and Hepatitis B vaccination if wanted, is provided, at no cost to the employee.

B. Tuberculosis Screening
Tuberculosis screening is conducted on all staff at time of employment. If a staff is unable to receive a tuberculosis skin test due to previous exposure or other reasons Occupational Health arranges follow-up testing deemed appropriate, this may include a chest x-ray or referral to a Tuberculosis Clinic. Compliance with these recommendations may be a condition of continued employment with Hillcrest Educational Centers.

C. Employee Injury Procedure – Human Bite Policy
While doing everything possible to prevent human bites, Hillcrest Educational Centers recognizes that, given the behavioral profiles of the students served by Hillcrest, human bites may occur. Hillcrest’s procedure for instances of skin-breaking bites to a staff from a student are as follows:
While other staff notify the Supervisor that a staff has been injured, and as soon as possible after receiving bite, cleanse the area with soap and water for 8-10 minutes and cover with a dry sterile dressing.
Complete an Accident Reporting & Treatment (ART) form, and notify the Administrative Injury Coordinator as soon as possible. Refer staff to Occupational Health or the Emergency Department for treatment.
Nursing will inform Occupational Health or the ER of the Hepatitis B and HIV status of the “biter”, if known.
Treatment at the hospital may include Tetanus booster, Hepatitis and HIV testing as well as antibiotics. These will be available at no cost to the employee.
The Administrative Injury Coordinator will follow up with the employee after the assessment to coordinate care and facilitate the employee’s return to work.
The nursing department will contact the parent/guardian and/or custodial agency of the “biter” in order to attempt to obtain consent for HIV testing of the student if this consent is not already in place. HEC will follow the recommendations of the parent/guardian/custodial agency of the “biter” regarding testing. Consent forms that require parent/guardian/custodial agency signature will be submitted to the hospital/ laboratory at the time of the blood test. The physician must also sign these forms. The Nursing Department will make the parent/guardian/custodial agency aware that the test results will be shared with the injured staff and documentation of the results will be kept in a confidential sealed envelope in the student’s chart. Documentation regarding the attempt to obtain consent will be made on the employee’s Staff Injury Form.
The exposed individual will be informed of the student’s HIV status by the Infection Control Nurse and /or Occupational Health, when the results become available.

Epidemiological studies show that AIDS is transmitted primarily via sexual contact or blood-to-blood contact. Researchers state that casual transmission of the virus has not occurred in close family environments, and opportunistic infections associated with AIDS do not present an appreciable risk to healthy individuals. Since there is no evidence of casual transmission by sitting near, living in the household, or caring for an individual with AIDS, the following policy and procedures are intended to insure the privacy and protect the rights of all students and employees of Hillcrest Educational Centers.

A. Legal Effect of This Policy Statement
This instrument is an expression of policy. It is not intended to and does not want to modify contractual or other legal rights held by the Hillcrest Educational Centers’ students or employees. This statement is not intended to and does not create or modify Hillcrest Educational Centers’ legal duty of care to students or employees.

B. Definitions:
• “HEC” means the Hillcrest Educational Centers, Inc.
• “Student” means a student at, who has been admitted to, enrolled in, and is residing at the agency, and who has not graduated, transferred, or discharged from HEC, or who has been otherwise removed from active status for any reason.
• “Employee” means a person, including an administrator, who receives wages or a salary from HEC.
• “HIV” means the Human Immunodeficiency Virus, sometimes referred to as the Human T-Lymphotropic Virus, Type III (HLTV-III) or the Human T-Lymphotropic Virus, Type III/Lymphaadenopathy Associated Virus (HLTV-III/LAV)
• “HIV test” means a properly performed test licensed by the U.S. Food and Drug Administration to detect the presence of HIV antibodies or antigens in a person’s blood.
• “AIDS” means Acquired Immune Deficiency Syndrome caused by HIV, as well as the condition sometimes referred to as AIDS-Related Complex (ARC).
• “Person with HIV infection” means a person who is infected with HIV, whether the person has AIDS or some symptoms of AIDS or is asymptomatic.
• “Person believed to have HIV infection” means a person believed to have HIV infection by a student or employee of HEC who has not reviewed the results of an HIV test on that person
• “Person believed to be at risk of HIV infection” means a person believed to be at risk of contracting the HIV infection by a student of employee of HEC.

C. General Policy
HEC will not discriminate against students or employees with HIV infection, students or employees believed to have the HIV infection, or students or employees believed to be at risk of the HIV infection on the basis of their perceived risk.
HEC will conform its policies regarding persons with HIV infection to the law, the best available scientific and medical evidence and the imperatives of human dignity, including privacy.
HEC will treat students and employees with HIV with respect and will, where necessary, accommodate such students and employees accordingly.
Since HIV is not known to be transmitted by food or air, according to the latest available scientific and medical evidence, HEC’s students and employees will follow standard sanitary procedures related to preparing food and cleaning eating-ware, regardless of the presence at HEC of a person with HIV infection or believed to have HIV infection.
Since HIV is not transmitted through sharing bathroom facilities, and standard sanitary procedures will prevent the growth of fungi and bacteria that may potentially cause illness to immune-compromised people, HEC’s students and employees will follow standard sanitary procedures in sharing and cleaning bathroom facilities, regardless of the presence at HEC of a person with HIV infection or believed to have HIV infection. Toothbrushes and razors should not be shared under any circumstances but in particular because of HIV status.
Since HIV is transmitted through blood, semen and vaginal secretions, as are other pathogens, and since according to the latest scientific and medical evidence HIV is not transmitted by sweat, feces, urine, vomit, tears, saliva, sputum or nasal mucous, unless these fluids contain blood, HEC’s students and employees will follow the Universal Precautions issued by the Center for Disease Control to clean up all bodily fluids, in handling materials, such as clothing and sanitary napkins, that have come in contact with bodily fluids, regardless of whether those bodily fluids are from a person with HIV infection or believed to have HIV infection and regardless of whether or not the body fluid is considered to contain blood.
HEC will educate students and employees about HIV infection/AIDS so that they will understand that they need not feel threatened by the simple presence at HEC of persons with HIV infection, persons believed to have HIV infection, or persons believed to be at risk of HIV infection.
HEC will not tolerate, and will strive to prevent and eliminate, any possible discrimination or harassment by students or employees directed at persons with HIV infection, persons believe to have HIV infection, or persons believed to be at risk of HIV infection.

D. Students
Students or prospective students, or their parents or guardians who know that the students or prospective students have HIV infection must disclose this information to the Coordinator of Nursing Services in order to facilitate appropriate medical treatment and counseling. Students with AIDS or with clinical evidence of HIV, who are too ill to receive treatment in a residential facility should have an alternative treatment in an appropriate medical or hospital setting.
It is assumed that HIV infected students can be served in residential facilities and that their diagnosis does not pose any special consideration in terms of physical facility requirements. In some unusual circumstances, however, a student may exhibit exceptional behavior that poses a theoretical risk to other students or employees. Such behavior would consist of engaging in sexual activity with other students, using parenteral drugs, frequent incontinence and public defecation. Those students whose behavior is determined to be unmanageable should be transferred to an appropriate setting.
HEC will not require prospective students to undergo HIV tests as a condition of admission. However, HIV testing may be done after admission in the following circumstances:
If the authorization for Diagnostic Testing has been signed by the legal guardian during the pre-placement process and that student has exposed peers or staff to his/her own body fluids.
If testing for HIV is requested by a student and the guardian consents and, an HEC physician orders testing. In this case, results would be available to HEC staff as outlined in section D, # 10 of this policy. If the student were 18 years old or older, and competent, guardian consent would not be needed.
Anonymous testing may be arranged, if requested by a student, for any student 13 years old or older, at the Neighborhood Health Clinic with no guardian consent, in this case results will not be made available to HEC or any HEC staff.
HEC will not deny admission to prospective students with HIV infection, believed to have HIV infection, or believed to be at risk of HIV infection, on the basis that they have HIV infection, are believed to have HIV infection, or are believed to be at risk of HIV infection. HIV infection is not considered a communicable infectious disease for the purpose of the provision elsewhere in this policy. HEC will not admit a student without verification that the student is free from communicable / infectious disease.
The person with HIV infection and /or AIDS has a somewhat greater risk of encountering infections in a residential program. In the event of an outbreak at HEC of a communicable disease, nursing will immediately notify the Medical Director of any students with HIV/AIDS infection and follow the directives given, including if necessary transfer and/ or quarantine within HEC, if possible, or at another facility.
HEC will not deny students with HIV infection , believed to have HIV infection, or believed to be at risk of HIV infection, any rights, privileges, benefits, or status as students on the basis that they have HIV infection, are believed to have HIV infection, or are believed to be at risk of HIV infection.
HEC will not require or request students undergo HIV testing as a condition for obtaining, or retaining rights, privileges, or benefits as a student,
If a Program Director has a reasonable belief that a student has HIV infection, the Program Director may request that the school physician refer the student to an appropriate medical setting for an HIV test and, if necessary, treatment. At an appropriate medical setting, the student will be administered an HIV test only after the student or the student’s parent or guardian voluntarily signs an informed consent form consistent with section D, #5 above.
A student’s HIV test results, whether positive or negative, will be placed in a sealed envelope labeled “Confidential Medical Information.” HEC will determine whether to maintain any such sealed envelopes in individual students’ medical records or in a separate file with restricted access. Release of test results shall be in accordance with Section D, # 10 below.
Testing for HIV antibody is not recommended for any purpose other than early intervention and treatment. HEC will restrict information regarding a student’s HIV status to as few employees as is possible, and will strive to maintain maximum feasible confidentiality. Only employees with an absolute need to know should have medical knowledge of a particular student. In individual situations this might include one or more of the following:
• Student
• Parent or guardian
• Administrators
• Direct care staff, if deemed appropriate by HEC’s community based healthcare provider for employees (e.g., occupational health) after an exposure.
• Nursing/medical staff
• Clinical staff
If the Medical Director determines that he/she should release a student’s HIV test results in circumstances not mandated by law to anyone other than an employee of HEC, the managing physician, or the student’s parent or guardian, HEC must first obtain the voluntary consent, in accordance with Section D, #3 above, of the student or the student’s parent or guardian.